AMC Entertainment Holdings Inc. (AMC) Jumps 10.02% on February 16

Equities Staff |

AMC Entertainment Holdings Inc. (AMC) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 10.02% to $22.51, representing a gain of $2.05 per share. Some 216,614 shares traded hands on 1,890 trades, compared with an average daily volume of 256,927 shares out of a total float of 97.4 million. The stock opened at $20.65 and traded with an intraday range of $22.52 to $20.65.

After today's gains, AMC Entertainment Holdings Inc. reached a market cap of $2.19 billion. AMC Entertainment Holdings Inc. has had a trading range between $36.13 and $19.28 over the last year, and it had a 50-day SMA of $22.38 and a 200-day SMA of $26.67.

The stock has a P/E Ratio of 22.

AMC Entertainment Holdings Inc is engaged in theatrical exhibition. It is principally involved in the theatrical exhibition business and owns, operates or has interests in theatres located in the United States.

AMC Entertainment Holdings Inc. is based out of Leawood, KS and has some 19,700 employees. Its CEO is Adam M. Aron.

For a complete fundamental analysis analysis of AMC Entertainment Holdings Inc., check out’s Stock Valuation Analysis report for AMC. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…